For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Scope of the Report:
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
The worldwide market for Flu Vaccine (Influenza Vaccine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Flu Vaccine (Influenza Vaccine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- CSL
- GSK
- Sanofi Pasteur
- Mylan
- AstraZeneca
- Pfizer
- Johnson & Johnson
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Whole Virus Vaccines
- Split Virus Vaccines
- Subunit Vaccines
- Live Attenuated Virus Vaccines
Market Segment by Applications, can be divided into
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine (Influenza Vaccine) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu Vaccine (Influenza Vaccine), with price, sales, revenue and global market share of Flu Vaccine (Influenza Vaccine) in 2017 and 2018.
Chapter 3, the Flu Vaccine (Influenza Vaccine) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine (Influenza Vaccine) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Flu Vaccine (Influenza Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Flu Vaccine (Influenza Vaccine) sales channel, distributors, customers, research findings and conclusion, appendix and data source.